Calibration model transfer refers to methods that let a multivariate calibration model built on one instrument, or under one set of conditions, remain valid on a different instrument or after conditions drift. Rather than rebuilding a model from scratch, techniques such as beta-coefficient correction, spectral standardization and scouting-set optimization adjust the existing model to fit new data. This matters commercially because rebuilding a validated calibration model can be slow and costly, especially in regulated environments like pharmaceutical process analytical technology or clinical diagnostics. The representative patent in this landscape, filed by Viavi Solutions, is a direct example of this transfer approach.

The dataset’s assignee ranking is led by one company holding 86 of the 691 records in scope, well ahead of the fifth-ranked assignee at 28 and tenth-ranked at 17. Beyond the top ten, which together hold 54.1% of all records, the field spreads across a long tail of 100 ranked assignees including instrument makers, pharmaceutical companies and universities. This pattern indicates a mature core method set controlled by a small group, with room for narrower application-specific claims further down the ranking.

Filings were flat between 2021 and 2024, moving from 6 to 6 annual records for a 0% three-year change, before rising to a peak of 27 in 2025. Because patent publication typically lags filing by around 18 months, the 2025 and 2026 figures are still incomplete and will likely revise upward. The honest characterization is a plateau through the early 2020s followed by a possible pickup, not a declining field.